Provided by Tiger Fintech (Singapore) Pte. Ltd.

Milestone Pharmaceuticals Inc.

1.88
-0.0100-0.53%
Post-market: 1.900.0200+1.06%19:59 EDT
Volume:1.46M
Turnover:2.74M
Market Cap:159.79M
PE:-2.24
High:1.93
Open:1.91
Low:1.86
Close:1.89
52wk High:2.75
52wk Low:0.6254
Shares:84.99M
Float Shares:78.81M
Volume Ratio:0.88
T/O Rate:1.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8376
EPS(LYR):-0.6674
ROE:-780.29%
ROA:-50.33%
PB:-9.00
PE(LYR):-2.82

Loading ...

Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA) and Milestone Pharmaceuticals (MIST)

TIPRANKS
·
Sep 15

Milestone Pharmaceuticals Initiated at Overweight by Wells Fargo

Dow Jones
·
Sep 11

Milestone Pharmaceuticals, Inc. : Wells Fargo Initiates Coverage With Overweight Rating

THOMSON REUTERS
·
Sep 11

Wells Fargo Initiates Milestone Pharmaceuticals at Overweight

MT Newswires Live
·
Sep 11

Milestone Pharmaceuticals Q2 EPS $(0.20) Misses $(0.17) Estimate

Benzinga
·
Aug 12

Milestone Pharmaceuticals Q2 Income From Operations USD -12.531 Million

THOMSON REUTERS
·
Aug 12

Milestone Pharmaceuticals Q2 Basic EPS USD -0.2

THOMSON REUTERS
·
Aug 12

Milestone Pharmaceuticals Inc - FDA Accepts Response to Crl for Cardamyst; Pdufa Date Dec 13, 2025

THOMSON REUTERS
·
Aug 12

Milestone Pharmaceuticals Inc - Raises Total Gross Proceeds up to $170 Mln in Public Offering

THOMSON REUTERS
·
Aug 12

Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

THOMSON REUTERS
·
Aug 12

Milestone Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
Aug 04

BUZZ-U.S. STOCKS ON THE MOVE-AeroVironment, Civista Bancshares, Meta

Reuters
·
Jul 12

BRIEF-Milestone Pharmaceuticals Announces Pricing Of $52.5 Million Public Offering

Reuters
·
Jul 11

BUZZ-U.S. STOCKS ON THE MOVE-Levi Strauss, Crypto Stocks, Delta

Reuters
·
Jul 11

Milestone Pharmaceuticals Says FDA Accepted for Review Cardamyst Nasal Spray Resubmission

MT Newswires Live
·
Jul 11

Milestone Pharmaceuticals Launches Securities Offering

MT Newswires Live
·
Jul 11

BRIEF-Milestone Pharmaceuticals Announces FDA Acceptance of the Company’s Response to the CRL for CARDAMYST™

Reuters
·
Jul 11

BRIEF-Milestone Pharmaceuticals Submits Response To The FDA’s CRL For CARDAMYST (Etripamil) Nasal Spray For PSVT Following Type A Meeting

Reuters
·
Jun 16

Milestone Pharmaceuticals Inc. Conducted Annual Shareholders Meeting

Reuters
·
Jun 13

Milestone Pharmaceuticals Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
Jun 05